Skip to main content


Fig. 4 | Cancer Nanotechnology

Fig. 4

From: Comparison of the effect of rhodium citrate-associated iron oxide nanoparticles on metastatic and non-metastatic breast cancer cells

Fig. 4

Effects of exposure to MRC for 24 h on DNA synthesis and cell cycle of MDA-MB-231 and MCF-7 cells. a Number of cells treated with NPs (24 h) in DNA synthesis (S phase) compared to the untreated control (0 h and 24 h). (*) p ≤ 0.05; (**) p ≤ 0.01. b Cell cycle assessment. Percentage of cells (treated with NPs with 100 μM MRC by 24 h) in gap 1 (G1), DNA synthesis (S) or gap 2 (G2) phase

Back to article page